130 related articles for article (PubMed ID: 16293885)
1. Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Mandalia S; Palmieri C; Nelson M; Gazzard B; Bower M
J Clin Oncol; 2005 Nov; 23(33):8538-40; author reply 8540-1. PubMed ID: 16293885
[No Abstract] [Full Text] [Related]
2. Malignant lymphoma in the HIV-positive patient.
Meister A; Hentrich M; Wyen C; Hübel K
Eur J Haematol; 2018 Jul; 101(1):119-126. PubMed ID: 29663523
[TBL] [Abstract][Full Text] [Related]
3. [Acquired immunodeficiency syndrome associated with Burkitt's leukemia diagnosed by ileus].
Tanabe Y; Muraoka A; Ryu T; Saito T
Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):150-2. PubMed ID: 18283903
[No Abstract] [Full Text] [Related]
4. Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.
Montoto S; Wilson J; Shaw K; Heath M; Wilson A; McNamara C; Orkin C; Nelson M; Johnson M; Bower M; Cwynarski K
AIDS; 2010 Mar; 24(6):851-6. PubMed ID: 20124971
[TBL] [Abstract][Full Text] [Related]
5. Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.
Spina M; Simonelli C; Talamini R; Tirelli U
J Clin Oncol; 2005 Nov; 23(31):8132-3; author reply 8133-4. PubMed ID: 16258119
[No Abstract] [Full Text] [Related]
6. Human immunodeficiency virus-associated Burkitt's lymphoma in oral cavity of Japanese patient.
Goto M; Onizawa K; Yanagawa T; Yamagata K; Shinozuka K; Nishikii H; Koganemaru H; Chiba S; Bukawa H
J Oral Maxillofac Surg; 2012 Aug; 70(8):1885-90. PubMed ID: 22079069
[No Abstract] [Full Text] [Related]
7. Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era.
Vasseur L; Prevot S; Mounier N; Costagliola D; Besson C
Eur J Cancer; 2020 Oct; 138():189-192. PubMed ID: 32896718
[No Abstract] [Full Text] [Related]
8. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
9. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment.
Colebunders R; Dohmen S; Van de Velde A; Pelgrom J; Hermans P
Acta Clin Belg; 2001; 56(5):321-2. PubMed ID: 11770227
[No Abstract] [Full Text] [Related]
10. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
[TBL] [Abstract][Full Text] [Related]
11. [Burkitt's lymphoma in a school boy with slow progression perinatally acquired HIV].
Beltrán-Arroyave C; Mesa C; Vásquez H; Hincapié N; Díaz-Díaz A
Rev Chilena Infectol; 2017 Oct; 34(5):507-510. PubMed ID: 29488597
[TBL] [Abstract][Full Text] [Related]
12. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.
Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC
East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes.
Gabarre J; Raphael M; Lepage E; Martin A; Oksenhendler E; Xerri L; Tulliez M; Audouin J; Costello R; Golfier JB; Schlaifer D; Hequet O; Azar N; Katlama C; Gisselbrecht C;
Am J Med; 2001 Dec; 111(9):704-11. PubMed ID: 11747850
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
[TBL] [Abstract][Full Text] [Related]
15. Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.
Schommers P; Hentrich M; Hoffmann C; Gillor D; Zoufaly A; Jensen B; Bogner JR; Thoden J; Wasmuth JC; Wolf T; Oette M; Müller M; Esser S; Vehreschild JJ; Fätkenheuer G; Wyen C
Br J Haematol; 2015 Mar; 168(6):806-10. PubMed ID: 25403997
[TBL] [Abstract][Full Text] [Related]
16. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
19. Burkitt's lymphoma of the duodenum in a patient with AIDS.
Corti M; Villafañe MF; Souto L; Schtirbu R; Narbaitz M; Soler Mde D
Rev Soc Bras Med Trop; 2007; 40(3):338-40. PubMed ID: 17653472
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS.
Boulanger E; Gérard L; Gabarre J; Molina JM; Rapp C; Abino JF; Cadranel J; Chevret S; Oksenhendler E
J Clin Oncol; 2005 Jul; 23(19):4372-80. PubMed ID: 15994147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
